Tender detail

Medicine rebate agreements for paliperidone and Trevicta

Summary

The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredient paliperidone and the brand-name medicine Trevicta. Agreements may be concluded at any time under the open-house model during the period from 1 December 2026 to 30 November 2028. Medicines on the BfArM list of paediatric medicines under Section 35(5a) SGB V are excluded from the procedure.

Reference number
26b74e61-3f22-415f-bf2b-51a82675aade
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-09-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.